NWBO
Northwest Biotherapeutics Inc

13,492
Mkt Cap
$323.54M
Volume
3.85M
52W High
$0.379
52W Low
$0.1926
PE Ratio
-4.53
NWBO Fundamentals
Price
$0.1945
Prev Close
$0.2014
Open
$0.195
50D MA
$0.2186
Beta
-0.02
Avg. Volume
2.26M
EPS (Annual)
-$0.0422
P/B
-5.06
Rev/Employee
$55,120.00
$416.06
Loading...
Loading...

About

Northwest Biotherapeutics, Inc. is a biotechnology company, which engages in the development of personalized immune therapies for cancer. It offers DCVax technology platform, which uses activated dendritic cells to mobilize a patient’s own immune system to attack their cancer. The company was founded by Alton L. Boynton on March 18, 1996 and is headquartered in Bethesda, MD.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
25

Frequently Asked Questions

What is Market Cap of Northwest Biotherapeutics Inc?
What is the 52-week high for Northwest Biotherapeutics Inc?
What is the 52-week low for Northwest Biotherapeutics Inc?
What is Northwest Biotherapeutics Inc stock price today?
What was Northwest Biotherapeutics Inc stock price yesterday?
What is the PE ratio of Northwest Biotherapeutics Inc?
What is the Price-to-Book ratio of Northwest Biotherapeutics Inc?
What is the 50-day moving average of Northwest Biotherapeutics Inc?
How many employees does Northwest Biotherapeutics Inc have?

Latest NWBO News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.